Jennifer L. Chain PhD

Dr. Jennifer Chain earned a PhD in Microbiology and Immunology from University of Oklahoma Health Sciences Center and is a certified cellular therapy expert with 26 years of experience in T cell immunology, product development, blood banking, and consulting. As Director of Research and Development at the Oklahoma Blood Institute, she led efforts to collect cellular starting material from over 1000 healthy donors for early-stage cell therapy companies. Her collaborative leadership and innovative donor recruitment strategies in this role were instrumental in serving the allogeneic cellular therapy industry. Serving as Chief Scientific Officer for Cytogrowth Solutions, Dr. Chain played a crucial role in the development of manufacturing procedures for blood- and cell-based culture materials. These contributions helped advance allogeneic cell therapies through process innovations and new product development. 

Dr. Chain also works as a consultant, helping blood centers and cell therapy companies develop procurement programs and screening strategies. She actively serves the Association for the Advancement of Blood and Biotherapies (AABB), where she engages in educational, strategic planning, and advocacy efforts in cellular therapy on both national and international levels.